Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Accenture
UBS
Fuji
Covington
Julphar
McKesson
Moodys
Express Scripts
Federal Trade Commission
Mallinckrodt

Generated: January 20, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 018421

« Back to Dashboard

NDA 018421 describes LITHIUM CITRATE, which is a drug marketed by West-ward Pharms Int and Wockhardt and is included in two NDAs. It is available from two suppliers. Additional details are available on the LITHIUM CITRATE profile page.

The generic ingredient in LITHIUM CITRATE is lithium citrate. There are fifteen drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the lithium citrate profile page.
Summary for 018421
Tradename:LITHIUM CITRATE
Applicant:West-ward Pharms Int
Ingredient:lithium citrate
Patents:0
Therapeutic Class:Bipolar Agents
Formulation / Manufacturing:see details
Pharmacology for NDA: 018421
Suppliers and Packaging for NDA: 018421
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
LITHIUM CITRATE lithium citrate SYRUP;ORAL 018421 NDA West-Ward Pharmaceuticals Corp 0054-3527 0054-3527-63 500 mL in 1 BOTTLE (0054-3527-63)
LITHIUM CITRATE lithium citrate SYRUP;ORAL 018421 NDA Precision Dose Inc. 68094-757 68094-757-62 3 TRAY in 1 CASE (68094-757-62) > 10 CUP, UNIT-DOSE in 1 TRAY > 5 mL in 1 CUP, UNIT-DOSE (68094-757-59)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:SYRUP;ORALStrengthEQ 300MG CARBONATE/5ML
Approval Date:Approved Prior to Jan 1, 1982TE:AARLD:Yes

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Johnson and Johnson
Julphar
Merck
Teva
McKesson
Harvard Business School
Medtronic
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot